U.K. Cell Culture Media Market Size & Outlook, 2026-2033
The cell culture media market in the UK is expected to reach a projected revenue of US$ 802.5 million by 2033. A compound annual growth rate of 14.6% is expected of the UK cell culture media market from 2025 to 2033.
In terms of revenue, UK accounted for 5.7% of the global cell culture media market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK cell culture media market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 802.5 million by 2033.
The UK is one of the key cell culture media markets in Europe. Rapidly growing pharmaceutical and biopharmaceutical industries are creating immense pressure on R&D for faster development of new treatment options. The use of cell culture media aids in development of in vivo models for enhanced testing of new molecules before human trials.
Furthermore, presence of organizations, such as Cancer Research UK, provides scope for development of new cell culture media by investigating custom cell growth requirements. Research grants in the country facilitate the uptake of cell culture products.
For instance, in March 2021, CN Bio received Innovate UK grant for testing human-relevant multi- and single-organ models for COVID-19 research, which includes the use of 3D cell culture for lungs. The use of cell culture media in such research studies facilitates faster development of novel therapeutic options. In addition, local presence of key players, such as Thermo Fisher Scientific, Inc. and Merck KGAA, is leading to high revenue growth in the market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Media Market Outlook will help companies and investors design strategic landscapes.
Serum-Free Media was the largest segment with a revenue share of 36.01% in 2024.
Horizon Databook has segmented the U.K. cell culture media market based on serum-free media, chemically defined media, specialty media, stem cell culture media, other cell culture media, classical media, immunology media covering the revenue growth of each sub-segment from 2021 to 2033.
The UK is one of the key cell culture media markets in Europe. Rapidly growing pharmaceutical and biopharmaceutical industries are creating immense pressure on R&D for faster development of new treatment options. The use of cell culture media aids in development of in vivo models for enhanced testing of new molecules before human trials.
Furthermore, presence of organizations, such as Cancer Research UK, provides scope for development of new cell culture media by investigating custom cell growth requirements. Research grants in the country facilitate the uptake of cell culture products.
For instance, in March 2021, CN Bio received Innovate UK grant for testing human-relevant multi- and single-organ models for COVID-19 research, which includes the use of 3D cell culture for lungs. The use of cell culture media in such research studies facilitates faster development of novel therapeutic options. In addition, local presence of key players, such as Thermo Fisher Scientific, Inc. and Merck KGAA, is leading to high revenue growth in the market.
U.K. Cell Culture Media Market Product Outlook (Revenue, USD Million , 2021-2033)
Serum-free Media
Chemically Defined Media
Specialty Media
Stem Cell Culture Media
Other Cell Culture Media
Classical Media
Immunology Media
U.K. Cell Culture Media Market Application Outlook (Revenue, USD Million , 2021-2033)
Drug Screening & Development
Biopharmaceutical Production
Diagnostics
Tissue Engineering & Regenerative Medicine
Other Applications
U.K. Cell Culture Media Market End Use Outlook (Revenue, USD Million , 2021-2033)
Research & Academic Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Other End Users
U.K. Cell Culture Media Market Type Outlook (Revenue, USD Million , 2021-2033)
Semi-solid & Solid Media
Liquid Media
Reasons to subscribe to Cell Culture Media Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Media Market Outlook databook
Our clientele includes a mix of Cell Culture Media Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Cell Culture Media Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Cell Culture Media Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.